0001209191-16-096129.txt : 20160205
0001209191-16-096129.hdr.sgml : 20160205
20160205191935
ACCESSION NUMBER: 0001209191-16-096129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160205
FILED AS OF DATE: 20160205
DATE AS OF CHANGE: 20160205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evoke Pharma Inc
CENTRAL INDEX KEY: 0001403708
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208447886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 LOMAS SANTA FE DRIVE
STREET 2: SUITE 270
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: 858-345-1494
MAIL ADDRESS:
STREET 1: 505 LOMAS SANTA FE DRIVE
STREET 2: SUITE 270
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'Onofrio Matthew J
CENTRAL INDEX KEY: 0001578770
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36075
FILM NUMBER: 161393660
MAIL ADDRESS:
STREET 1: C/O EVOKE PHARMA, INC.
STREET 2: 12555 HIGH BLUFF DR SUITE 385
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-05
0
0001403708
Evoke Pharma Inc
EVOK
0001578770
D'Onofrio Matthew J
C/O EVOKE PHARMA, INC.
505 LOMAS SANTA FE DRIVE, SUITE 270
SOLANA BEACH
CA
92075
0
1
0
0
Exec VP, Chief Bus. Officer
Stock Option (Right to Buy)
8.67
2016-02-05
4
D
0
94250
D
2023-12-01
Common Stock
94250
0
D
Stock Option (Right to Buy)
6.22
2016-02-05
4
D
0
70000
D
2025-03-05
Common Stock
70000
0
D
Stock Option (Right to Buy)
3.04
2016-02-05
4
A
0
70687
0.00
A
2023-12-01
Common Stock
70687
70687
D
Stock Option (Right to Buy)
3.04
2016-02-05
4
A
0
52500
0.00
A
2025-03-05
Common Stock
52500
52500
D
The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period following the date of grant (12/2/2013), subject to the reporting person's continued service to the Issuer through each such vesting date.
On February 5, 2016, the Issuer canceled an option granted on December 2, 2013. In exchange for the canceled option, the reporting person received 70,687 options to purchase common stock.
The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2015, subject to the reporting person's continued service to the Issuer through each such vesting date.
On February 5, 2016, the Issuer canceled an option granted on March 6, 2015. In exchange for the canceled option, the reporting person received 52,500 options to purchase common stock.
The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on January 1, 2016, subject to the reporting person's continued service to the Issuer through each such vesting date.
/s/ Matthew J. D'Onofrio
2016-02-05